Operating Lease, Right-of-Use Asset of Phathom Pharmaceuticals, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Phathom Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Phathom Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $2,694,000, a 223% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Phathom Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,694,000 +$1,861,000 +223% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $873,000 -$177,000 -17% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $388,000 -$876,000 -69% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $613,000 -$862,000 -58% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 $833,000 -$849,000 -50% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $1,050,000 -$836,000 -44% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $1,264,000 -$824,000 -39% 31 Mar 2024 10-Q/A 14 Jun 2024 2024 Q1
Q4 2023 $1,475,000 -$812,000 -36% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $1,682,000 -$800,000 -32% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $1,886,000 -$671,000 -26% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $2,088,000 +$293,000 +16% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $2,287,000 +$373,000 +19% 31 Dec 2022 10-K/A 14 Jun 2024 2023 FY
Q3 2022 $2,482,000 +$451,000 +22% 30 Sep 2022 10-Q/A 09 Nov 2022 2022 Q3
Q2 2022 $2,557,000 +$410,000 +19% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $1,795,000 -$466,000 -21% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $1,914,000 -$459,000 -19% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $2,031,000 -$454,000 -18% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $2,147,000 -$467,000 -18% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $2,261,000 +$1,322,000 +141% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $2,373,000 +$1,440,000 +154% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $2,485,000 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $2,614,000 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $939,000 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 $933,000 31 Dec 2019 10-K 30 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.